accountSAN FRANCISCO (MarketWatch) -- Johnson & Johnson (NYSE:JNJ
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
JOHNSON & JOHNSON
Johnson & Johnson is a global pharmaceutical, medical devices and consumer packaged goods manufacturer. Founded in 1886, J&J now includes about 250 subsidiaries in more than 57 countries. A household name in the U.S., the company’s products are sold in more than 175 countries. The topic covers Johnson & Johnson the company, its products and market updates.
Johnson & Johnson is part of Business Exchange, suggested by
Carlton St Bernard.
This topic contains
1,306 news
and
1,891 blog
items.
Read updated news, blogs, and resources about Johnson & Johnson. Find user-submitted articles and reactions on Johnson & Johnson from
like-minded professionals.
News
Recent news on this topic.
are products manufacturer Johnson & Johnson on Wednesday said it would acquire global manufacturer of orthopaedic...
CNBC's Brian Shactman has the details on Johnson & Johnson's annual shareholder meeting
value is about $4.8 billion. Now the company is attempting its biggest deal ever [ Bloomberg ] J&J: Its $21.
April 28 (Bloomberg) -- Johnson & Johnson���s newfound dominance of the orthopedic-device market, cemented by its...
Nations Face Quandary in Syria Karzai Told to Dump U.S. S&P���s Japan Outlook Goes Negative Corporate J&J to...
It?s Deal Time: Johnson & Johnson is buying Synthes, which makes surgical devices used for orthopedic and traumatic...
Reuters Johnson & Johnson���s plan to buy Swiss-listed medical device maker Synthes will probably succeed in the...
CompaniesEconomy International The Buzz Street Sweep Corrections Pre-market Trading After-hours Trading US Stocks Bonds...
US healthcare giant Johnson & Johnson (J&J) has agreed to buy Swiss medical devices company Synthes in a deal...
April 27 (Bloomberg) -- Johnson & Johnson agreed to buy Synthes Inc. for $21.3 billion, adding devices to treat...
also out on Wednesday. Economists surveyed by Briefing.com expect an increase of 1.8% in March.Companies: Johnson &...
Extract not available.
Extract not available.
test leadership already grappling with manufacturing problems and investor concerns about mismanagement.
April 27 (Bloomberg) -- Johnson & Johnson agreed to buy Synthes Inc. for $21.3 billion in the biggest purchase of...
Extract not available.
by the European Medicines Agency. Telaprevir would be marketed in Europe by Vertex and New Brunswick, New Jersey-based...
equipment improved and the company reduced spending. Synthes Inc. climbed 1.5 percent to 148.7 francs as Johnson &...
The email address you have entered is already in use. Please re-enter the email address.
well as its first ever press conference as well as the impact on the market. In deal news, Johnson & Johnson added...
Extract not available.
personal data and create visualizations, reports Nick Bilton on the Bits blog. Read more �� Previous Article Inside...
A general view shows Swiss medical devices maker Synthes' headquarters in Oberdorf, April 25, 2011. Johnson &...
Top Sources: Johnson & Johnson
- BusinessWeek
- Financial Times
- TheStreet.com
- New York Times
- Reuters
- Motley Fool
- thedeal.com
- bloomberg.com
- Wall Street Journal Online
- MarketWatch
Post a Job
Jobs in this Topic
Registered Nurse Part Time 24 Hours J Labor & Delivery Side A
Vidant Medical Center
|
Greenville, NC
Posted: May 11
PA Emergency Medicine Opportunity supporting H-1 and J-1 Visas
CompHealth
|
Pennsylvania
Posted: Apr 2